Tonghe Pharmaceutical: "Fumarate Vornorasin" raw material drug approved by CDE

Tonghe Pharmaceutical announced that recently, according to the “Raw Material and Packaging Registration Information Publicity” platform of the National Medical Products Administration’s Center for Drug Evaluation (CDE), the company’s submitted “Fumarate VenoLar” raw material drug has passed CDE approval.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin